Skip to content

The investigation of hemodynamic effects of intravenous Ketamine after spinal anaesthesia for caesarean section

The investigation of hemodynamic effects of intravenous Ketamine after spinal anaesthesia for caesarean section

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101293468N4
Enrollment
60
Registered
2011-04-04
Start date
2010-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia for cesarean delivery. Delivery by elective caesarean section

Interventions

Intervention 1: Intervention group: Ketamine 30 milligram + 1 milligram midazolam = 2 milliliter intravenously. Intervention 2: Control group: 1 milligram midazolam = 2 CC.
Prevention
Intervention group: Ketamine 30 milligram + 1 milligram midazolam = 2 milliliter intravenously
Control group: 1 milligram midazolam = 2 CC

Sponsors

Vice chancellor for research, Shahid Sadoughi University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- ASA=1,2; 2- No hx of recent head rrauma; 3- NO hx of opium addiction; 4- NO hx of psychiatric drug consumption; 5- NO hx of hallucination; 6- NO hx of delirium; 7- NO hx of hypertension; 8- NO hx of ischemic heart disease; 9-NO hx of known hypersensitivity to study drug; 10- Elective cesarean; 11- age above 18 years. Exclusion criteria: 1- hypersensitivity to study drug; 2- need to additive dose of Ketamine; 3- unexpected event during surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemodynamic variable. Timepoint: 2 minute. Method of measurement: non invasive hemodynamic monitoring.

Secondary

MeasureTime frame
Post operative pain. Timepoint: 1 hour. Method of measurement: VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShekoufeh Behdad

Shahid Sadoughi hospital

drbehdad@yahoo.com , hajiesmaeili@ssu.ac.ir+98 35 1822 1386

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026